Sinonasal Squamous Cell Carcinoma in the Netherlands: A Population-Based Study of 568 Cases Diagnosed in 2008-2021

• Published in: Head & neck
• Main Authors: van de Velde, Lise J, Scheurleer, W F Julius, Braunius, W Weibel, Speksnijder, Caroline M, de Ridder, Mischa, Devriese, Lot A, de Bree, Remco, Breimer, Gerben E, Rijken, Johannes A, van Dijk, Boukje A C
• Format: Journal Article
• Language: English
• Published: United States 16-10-2024
• Subjects: paranasal sinus cancer; head and neck cancer; sinonasal cancer; nose cancer; squamous cell carcinoma
• ISSN: 1043-3074; 1097-0347; 1097-0347
• DOI: 10.1002/hed.27961

Sinonasal squamous cell carcinoma is known for its rarity and poor prognosis. This study aims to investigate the trends in the incidence of sinonasal squamous cell carcinoma in the Netherlands and to analyze patient characteristics and treatment practices in order to assess their relation with patient outcomes.
In this prospectively designed population-based cohort study, all patients diagnosed with sinonasal squamous cell carcinoma between 2008 and 2021 in the Netherlands were included. Patients with a squamous cell carcinoma of the nasal vestibule were excluded, leading to a definitive study population of 568 cases.
The annual incidence rate for the overall population displayed a slight upward trend over the inclusion period with an annual percentage change of 1.6%. The 5-year overall, disease-free, and relative survival were 43.0%, 52.0%, and 47.2%, respectively. Relative survival decreased marginally over the course of the inclusion period.
Sinonasal squamous cell carcinoma is rare with approximately stable incidence rates. There is a limited, non-statistically significant, decrease in survival between 2008 and 2021. Therefore, there is a clear need for innovative treatment approaches to improve outcomes for patients with sinonasal squamous cell carcinoma.